Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) — Hollywood, Florida

Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) is a clinical research site located in Hollywood, Florida, United States 33020.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) has participated in 1 clinical trials.

Therapeutic areas: End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728)?

Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) conducted?

Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) has 1 clinical trials on record. Their work covers End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Is Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) accredited by Crixeo Health?

Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Elixia Clinical Research Collaborative (CRC) - Southeast Florida ( Site 0728)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.